Literature DB >> 20157840

Highlights from the II International Symposium of Thrombosis and Anticoagulation (ISTA), October 22-23, 2009, São Paulo, Brazil.

Renato D Lopes1, David Garcia, Richard C Becker, Christopher B Granger, L Kristin Newby, John H Alexander, E Marc Jolicoeur, Allison Handler, Karen S Pieper, Antonio C Carvalho, Helio P Guimaraes, Dalton A F Chamone, Antonio C Baruzzi, Fabio S Machado, Ari Timerman, Antonio C Lopes.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20157840     DOI： 10.1007/s11239-010-0454-8

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  56 in total

1.  Ethical and scientific implications of the globalization of clinical research.

Authors:  Seth W Glickman; John G McHutchison; Eric D Peterson; Charles B Cairns; Robert A Harrington; Robert M Califf; Kevin A Schulman
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 91.245

2.  Risk stratification in non-ST-segment elevation acute coronary syndromes: troponin alone is not enough.

Authors:  Philippe Gabriel Steg; Gordon FitzGerald; Keith A A Fox
Journal:  Am J Med       Date:  2009-02       Impact factor: 4.965

3.  Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.

Authors:  Larry B Goldstein; Robert Adams; Mark J Alberts; Lawrence J Appel; Lawrence M Brass; Cheryl D Bushnell; Antonio Culebras; Thomas J Degraba; Philip B Gorelick; John R Guyton; Robert G Hart; George Howard; Margaret Kelly-Hayes; J V Ian Nixon; Ralph L Sacco
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

4.  Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Robert A Harrington; Richard C Becker; Christopher P Cannon; David Gutterman; A Michael Lincoff; Jeffrey J Popma; Gabriel Steg; Gordon H Guyatt; Shaun G Goodman
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

5.  Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry).

Authors:  Renato D Lopes; E Magnus Ohman; Christopher B Granger; Emily F Honeycutt; Kevin J Anstrom; Peter B Berger; Eric M Crespo; Gustavo B F Oliveira; Stephan Moll; David J Moliterno; Charles S Abrams; Richard C Becker
Journal:  Am J Cardiol       Date:  2009-11-01       Impact factor: 2.778

Review 6.  Genetic link between cancer and thrombosis.

Authors:  Carla Boccaccio; Paolo M Comoglio
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

Review 7.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

Review 8.  Risk factors for venous thromboembolism.

Authors:  Frederick A Anderson; Frederick A Spencer
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

9.  Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.

Authors:  Renato D Lopes; Laine E Elliott; Harvey D White; Judith S Hochman; Frans Van de Werf; Diego Ardissino; Torsten T Nielsen; W Douglas Weaver; Petr Widimsky; Paul W Armstrong; Christopher B Granger
Journal:  Eur Heart J       Date:  2009-06-06       Impact factor: 29.983

10.  Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.

Authors:  Stephen D Wiviott; Eugene Braunwald; Dominick J Angiolillo; Simha Meisel; Anthony J Dalby; Freek W A Verheugt; Shaun G Goodman; Ramon Corbalan; Drew A Purdy; Sabina A Murphy; Carolyn H McCabe; Elliott M Antman
Journal:  Circulation       Date:  2008-08-31       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.